Breaking News Instant updates and real-time market news.

CYTK

Cytokinetics

$9.09

-0.05 (-0.55%)

07:31
10/18/16
10/18
07:31
10/18/16
07:31

Cytokinetics announces first patient enrolled in VIGOR-ALS clinical trial

Cytokinetics announced the first patient has been enrolled in Ventilatory Investigations in Global Open-Label Research in ALS, or VIGOR-ALS, an open-label extension clinical trial designed to assess the long-term safety and tolerability of tirasemtiv, in patients with ALS who have completed their participation in VITALITY-ALS, the Phase 3 clinical trial designed to assess the effects of tirasemtiv versus placebo on slow vital capacity and other measures of respiratory and skeletal muscle function.

  • 20

    Oct

  • 27

    Oct

  • 29

    Nov

CYTK Cytokinetics
$9.09

-0.05 (-0.55%)

11/09/15
ROTH
11/09/15
NO CHANGE
ROTH
Cytokinetics reported positive data, says Roth Capital
Roth Capital says that Cytokinetics' (CYTK) COSMIC-HF met its primary endpoint and all of its secondary endpoints in a study. The firm raised its price target on the stock to $22 from $18. It notes that Amgen (AMGN) is partnering with Cytokinetics on the drug. The firm keeps a Buy rating on Cytokinetics.
12/16/15
PIPR
12/16/15
NO CHANGE
Target $24
PIPR
Overweight
Cytokinetics price target raised to $24 from $17 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised its price target for Cytokinetics to $24 citing greater conviction in the company's pipeline assets ahead of its "busy" 2016. Piper views Cytokinetics as the leader in muscle-biology and reiterates an Overweight rating on the name.
06/21/16
FBRC
06/21/16
NO CHANGE
Target $24
FBRC
Outperform
FBR views Cytokinetics as attractive despite 36% rally
Even with shares up 36% since added to his firm's Alpha Generator list in March, FBR Capital analyst Vernon Bernardino still views shares of Cytokinetics (CYTK) as attractive for an initial investment. The analyst believes partner Amgen (AMGN) will exercise its option and advance omecamtiv mecarbil into Phase III testing in heart failure. Bernardino keeps an Outperform rating on the shares with a $24 price target.

TODAY'S FREE FLY STORIES

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

, CI

Cigna

09:35
09/25/17
09/25
09:35
09/25/17
09:35
Hot Stocks
Rennova Health announces appeals court win for Cigna suit »

Rennova Health (RNVA)…

RNVA

Rennova Health

$0.22

0.0086 (4.07%)

CI

Cigna

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$79.70

0.09 (0.11%)

09:31
09/25/17
09/25
09:31
09/25/17
09:31
Hot Stocks
Daimler Trucks tests truck platooning on public highways in the U.S. »

As the first commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPZ

Williams Partners

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams Partners initiated  »

Williams Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Initiation
Williams initiated  »

Williams initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands' Taco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Hot Stocks
Intercept says talks with FDA 'evolving' »

When asked on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMMF

Summit Financial Group

$25.01

0.22 (0.89%)

09:30
09/25/17
09/25
09:30
09/25/17
09:30
Downgrade
Summit Financial Group rating change  »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCMI

PCM, Inc.

$13.20

0.2 (1.54%)

09:29
09/25/17
09/25
09:29
09/25/17
09:29
Hot Stocks
PCM, Inc. acquires Stack Technology, subsidiaries »

PCM, Inc. has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

BIIB

Biogen

$318.46

3.43 (1.09%)

, NVO

Novo Nordisk

09:28
09/25/17
09/25
09:28
09/25/17
09:28
Hot Stocks
Biogen apponts Camille Lee as SVP, Alzheimer's Disease Therapeutic Area »

Biogen (BIIB) announced…

BIIB

Biogen

$318.46

3.43 (1.09%)

NVO

Novo Nordisk

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:27
09/25/17
09/25
09:27
09/25/17
09:27
Conference/Events
Wells Fargo financial team holds an analyst/industry conference call »

Wells Fargo Financial…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

, PTN

Palatin

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Exelixis (EXEL),…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

PTN

Palatin

AGN

Allergan

ICPT

Intercept

$61.59

-12.11 (-16.43%)

GPC

Genuine Parts

TGT

Target

LLY

Eli Lilly

AAPL

Apple

$151.89

-1.5 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

TSLA

Tesla

$351.09

-15.39 (-4.20%)

, GM

General Motors

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Periodicals
China may ease foreign automaker rules aiding Tesla, WSJ reports »

China officials may ease…

TSLA

Tesla

$351.09

-15.39 (-4.20%)

GM

General Motors

VLKAY

Volkswagen

$34.57

0.46 (1.35%)

F

Ford

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 03

    Oct

  • 26

    Oct

SBRA

Sabra Health Care

$22.21

0.03 (0.14%)

09:23
09/25/17
09/25
09:23
09/25/17
09:23
Initiation
Sabra Health Care initiated  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

09:20
09/25/17
09/25
09:20
09/25/17
09:20
General news
Treasury Action: supply is on tap this week »

Treasury Action: supply…

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/25/17
09/25
09:18
09/25/17
09:18
Options
Overnight activity included 98 trades in SPX and 33 trades in VIX »

98 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$24.50

1.04 (4.43%)

09:17
09/25/17
09/25
09:17
09/25/17
09:17
Recommendations
Nutanix analyst commentary  »

Nutanix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:16
09/25/17
09/25
09:16
09/25/17
09:16
Hot Stocks
Amazon signs first-look production deal with Casey Affleck's Sea Change Media »

Amazon Studios has closed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

09:15
09/25/17
09/25
09:15
09/25/17
09:15
General news
The Hurricane Lift for U.S. Producer Sentiment Has Begun: »

The Hurricane Lift for…

TUWOY

Tullow Oil

$1.19

0.08 (7.21%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Upgrade
Tullow Oil rating change  »

Tullow Oil upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$151.89

-1.5 (-0.98%)

, S

Sprint

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Apple, Sprint, STMicroelectronics analyst commentary  »

Initial Apple iPhone 8…

AAPL

Apple

$151.89

-1.5 (-0.98%)

S

Sprint

STM

STMicroelectronics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 22

    Oct

  • 16

    May

FINL

Finish Line

$9.73

0.51 (5.53%)

09:14
09/25/17
09/25
09:14
09/25/17
09:14
Recommendations
Finish Line analyst commentary  »

Finish Line takeout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.33

-0.12 (-0.19%)

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Recommendations
Carnival analyst commentary  »

Carnival estimates raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

YUM

Yum! Brands

09:13
09/25/17
09/25
09:13
09/25/17
09:13
Conference/Events
Yum! Brands management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

09:12
09/25/17
09/25
09:12
09/25/17
09:12
Hot Stocks
Amazon signs multi-year deal with Amy Sherman-Palladino, Daniel Palladino »

Amazon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

MSM

MSC Industrial

09:11
09/25/17
09/25
09:11
09/25/17
09:11
Initiation
MSC Industrial initiated  »

MSC Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.